WARREN, N.J., March 17, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing…
Event to discuss unmet need in FSHD, key measures of disease progression and Phase 3…
Led by Kizoo Technology Capital, the Seed round will be used to advance Revel Pharmaceuticals’…
FMX114 demonstrated preliminary clinical safety and pharmacokinetics in Phase 1b study VYN201 shows promising preclinical…
Management to host conference call and webcast at 4:30 pm ET IRVINE, Calif., March 17,…
PRINCETON, N.J., March 17, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Two pre-clinical trials based on MEAI exhibited a significant suppressive effect on alcohol consumption in…
BOSTON, March 17, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical…
SOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
TORONTO, March 17, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…
GAITHERSBURG, Md., March 17, 2022 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI) and Zephyr AI (Zephyr)…
IND submission for lead program CNTY-101 on track for mid 2022; Phase 1 ELiPSE-1 trial…
VANCOUVER, British Columbia, March 17, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the…
JENA, Germany, March 17, 2022 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
CLN-081 clinical data support a differentiated clinical profile; regulatory update planned for first quarter 2022…
CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced the…
LEAMINGTON, Ontario, March 17, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”)…
TORONTO, Ontario and CAMBRIDGE, Massachusetts , March 17, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc….
WINNIPEG, Manitoba, March 17, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
Full-Year 2021 Total Revenues of $23.8 Million; Product Revenues Up 46% Positive Top-Line Data for…